Loading clinical trials...
Loading clinical trials...
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Conditions
Interventions
Letrozole
Placebo
Locations
806
United States
Regional Medical Center
Anniston, Alabama, United States
Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
Providence Cancer Center
Anchorage, Alaska, United States
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
Start Date
August 1, 2006
Primary Completion Date
August 25, 2016
Completion Date
April 1, 2025
Last Updated
March 22, 2024
NCT07040891
NCT07547774
NCT06257264
NCT07347600
NCT07525869
NCT04740697
Lead Sponsor
NSABP Foundation Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions